骨质疏松性骨折的新认识
New understanding of osteoporotic fracture
摘要
骨质疏松症防治的根本目的在于降低人群中骨折的发病率.这种防治要根据骨密度(BMD)、骨转换生化指标,以及一系列骨质量测量指标的了解而进行.那么"为什么骨折会发生?如何发生?谁是骨折最危险的人?临床治疗能否降低骨折危险?"等,都是近些年来讨论的热点问题.
出处
《中国骨肿瘤骨病》
2003年第6期365-367,共3页
Chinse Journal Of Bone Tumor And Bone Disease
参考文献12
-
1[1]Seeman E. Why is osteoporosis complicated by fractures? Osteoporos Int,2002,13 Suppl 1:1.
-
2[2]Legrand ER, Chappard D, Insalaco P, et al. Trabecular bone microarchitecture is related to clinical risk factors in osteoporosis in men. Osteoporos Int,2002,13 suppl 1:5.
-
3[3]Duan YB, Beck TJ, Wang XF, et al. Structural and biomechanical basis for femoral neck bone fragility in men and women. Osteoporos Int, 2002,13suppl 1:6.
-
4[4]Boonen S, Autier P, Collins J, et al. Colles' fracture and subsequent hip- fracure risk in men: a meta- analysis. Osteoporos Int, 2002, 13suppl 1:8.
-
5[5]Olsson J, Johnell O, Kanis J, et al. Previous fracture combined with forearm BMD measurement as a predictor of new fractures. Osteoporos Int,2002,13 suppl 1:10.
-
6[6]Johnell O, De Laet C, Johansson H, et al. Oral corticosteroids increase fracture risk independently of BMD. Osteoporos Int,2002,13 suppl 1:14.
-
7[7]National Osteoporosis Foundation. Osteoporosis:review of the evidence for prevention, diagnosis, and treatment and cost- effectiveness analysis:status report. Osteoporos Int, 1998,8 suppl 4:1 - 88.
-
8[8]Cooper C, Atkinson EJ, O' Fallon WM, et al. Incidence of clinically diagnosed vertebral fractures:a population- based study in Rochester, Minnesota, 1985 - 1989.J Bone Miner Res, 1992,7:221 - 227.
-
9[9]Van der Klift M, de Laet CEDH, McCloskey EV, et al. Risk factors for incident vertebral fractures in men and women: the Rotterdam study. Osteoporos Iht, 2002,13 suppl 1: 67.
-
10[10]Cummings SR,Nevitt MC,Browner WS,et al. Risk factors for hip fracture in white women. N Engl J Med, 1995,332:767- 773.
-
1陈祖亮.骨质疏松症诊断技术新进展[J].中华医学信息导报,2002,17(6):14-14.
-
2姜荷艳,王锐,孙立军.雷洛昔芬对绝经后骨质疏松症的疗效观察[J].实用预防医学,2010,17(3):551-552. 被引量：3
-
3刘石平.绝经后骨质疏松症防治中的雌激素替代治疗[J].国外医学（老年医学分册）,2000,21(4):145-148. 被引量：4
-
4姚珍薇,欧文君.钙剂在绝经后骨质疏松症防治中的合理应用[J].中华内分泌外科杂志,2009,3(2):80-82. 被引量：6
-
5李双庆.骨密度与某些骨转换生化指标在骨质疏松疗效观察中的应用[J].华西医学,2001,16(4):498-498. 被引量：1
-
6卢亚祖,王昌富.骨转换生化指标的临床应用[J].中国优生与遗传杂志,2007,15(4):43-44. 被引量：2
-
7白玉,程慧,周锋涛,张国永,王葳葳,马富强,史炎鑫,王爱国.强骨胶囊对老年性骨质疏松症患者骨密度及骨转换生化指标的影响[J].风湿病与关节炎,2016,5(3):22-24. 被引量：11
-
8陶雪花,王永斌.健康教育在骨质疏松症防治中的重要性[J].中国社区医师（医学专业）,2012,14(3):373-373. 被引量：5
-
9卢士燕,高羽.绝经后骨质疏松妇女血清瘦素与骨密度及骨转换生化指标的关系[J].国外医学（计划生育分册）,2004,23(1):62-62.
-
10唐萍,吕铭.微创经皮肾镜钬激光碎石术治疗肾结石护理体会[J].护理实践与研究,2009,6(23):36-37. 被引量：9
